Skip to Main Content

Paper Details

Early Adoption of Anti-SARS-CoV-2 Pharmacotherapies Among US Veterans With Mild to Moderate COVID-19, January and February 2022.
JAMA Netw Open
8
2022
Author NameAffiliation
Denise M Hynes
Denise M HynesCollege of Public Health and Human Sciences, Oregon State University
Denise M HynesCenter for Quantitative Life Sciences, Oregon State University
Mazhgan Rowneki
Francesca CunninghamVeterans Affairs Center for Medication Safety - Pharmacy Benefit Management (PBM) Services
Edward J Boyko
Theodore J IwashynaCenter for Clinical Management Research
Theodore J IwashynaUniversity of Michigan Medical School ann arbor
Matthew L MaciejewskiDurham VA Medical Center
Matthew L MaciejewskiDuke University School of Medicine
Matthew L MaciejewskiDuke-Margolis Center for Health Policy, Duke University
Grant D Huang
  • 1 - 12

Datasets